Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017, Article ID 8035013, 8 pages
https://doi.org/10.1155/2017/8035013
Clinical Study

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant

1Ophthalmology Department, Avicenne Hospital, DHU Vision and Handicaps, Paris XIII University, 125 rue de Stalingrad, 93000 Bobigny, France
2Centre d’Imagerie et de Laser, 11 rue Antoine Bourdelle, Paris, France
3Ophthalmology Department, Pitié Salpétrière Hospital, DHU Vision and Handicaps, Paris VI University, Paris, France

Correspondence should be addressed to Audrey Giocanti-Auregan; rf.oohay@itnacoigyerdua

Received 5 April 2017; Revised 19 June 2017; Accepted 16 July 2017; Published 16 August 2017

Academic Editor: Thomas Bertelmann

Copyright © 2017 Antoine Herbaut et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Antoine Herbaut, Franck Fajnkuchen, Lise Qu-Knafo, Sylvia Nghiem-Buffet, Bahram Bodaghi, and Audrey Giocanti-Auregan, “Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant,” Journal of Ophthalmology, vol. 2017, Article ID 8035013, 8 pages, 2017. https://doi.org/10.1155/2017/8035013.